Genzyme Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Genzyme stocks.

Genzyme Stocks Recent News

Date Stock Title
Jul 1 BMRN Here’s Why Parnassus Value Equity Fund Sold BioMarin Pharmaceutical (BMRN)
Jul 1 PTCT PTC Therapeutics (PTCT) Down on Negative CHMP Opinion on DMD Drug
Jul 1 ALNY Alnylam, Lilly, AstraZeneca among best performing pharmas, biotechs in Q2
Jun 30 ALNY Rivian Automotive And Carvana Were Among The 10 Biggest Large Cap Gainers Last Week (June 23-June 29): Are These In Your Portfolio?
Jun 29 ALNY Selling US$7.7m Of Alnylam Pharmaceuticals Stock Rewarded Insiders
Jun 28 PTCT Biggest stock movers today: PLUG, NKE, DJT, and more
Jun 28 PTCT PTC Therapeutics Tumbles After European Regulators Reject Its Drug — Again
Jun 28 PTCT PTC faces another Duchenne drug rejection; Coherus sells Humira biosimilar
Jun 28 PTCT PTC drops as EU panel declines to recommend Translarna marketing renewal
Jun 28 PTCT CHMP Issues Negative Opinion on Translarna™ Following European Commission Request for Review
Jun 27 EXAS Exact Sciences initiated at sector outperform at Scotiabank on advanced diagnostics
Jun 27 ALNY Peering Into Alnylam Pharmaceuticals's Recent Short Interest
Jun 27 ALNY Biotech Stock Roundup: ALNY Up on Study Success, ALIM on Merger News & Other Updates
Jun 26 EXAS Exact Sciences gains as TD Cowen sees 25% price hike for next-gen Cologuard
Jun 25 ALNY Alnylam (ALNY) Soars as Heart Disease Drug Study Meets Goals
Jun 25 ALNY Top Three US Stocks Estimated Below Intrinsic Value In June 2024
Jun 25 ALNY RNAi: Winning In The Clinic, Now For The Market
Jun 25 ALNY Nvidia, Affirm Holdings, Carnival Corp, Alnylam Pharmaceuticals, Tesla: Why These 5 Stocks Are On Investors' Radars Today
Genzyme

Sanofi Genzyme is an American biotechnology company based in Cambridge, Massachusetts. Since its acquisition in 2011, Genzyme has been a fully owned subsidiary of Sanofi. In 2010, Genzyme was the world’s third-largest biotechnology company, employing more than 11,000 people around the world. As a subsidiary of Sanofi, Genzyme has a presence in approximately 65 countries, including 17 manufacturing facilities and 9 genetic-testing laboratories. Its products are also sold in 90 countries. In 2007, Genzyme generated $3.8 billion in revenue with more than 25 products on the market. In 2006 and 2007, Genzyme was named one of Fortune Magazine’s “100 Best Companies to Work for”. The company donated $83 million worth of products worldwide; in 2006, it made $11 million in cash donations. In 2005, Genzyme was awarded the National Medal of Technology, the highest level of honor awarded by the president of the United States to America’s leading innovators.

Browse All Tags